Back

A novel therapeutic approach with additional tolvaptan for the patients with hypoalbuminemia or proteinuria.

29 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Acute heart failure Acute heart failure (therapy) HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Doctor Koji Takagi

Momentum Research, Inc., Chapel Hill (United States of America)

51 More presentations in this session

Presentation thumbnail
Immune-mediated inflammation and acute left ventricular failure in myocardial infarction
Professor A. Babaeva (Volgograd, RU)
Presentation thumbnail
The chloride theory, a unifying hypothesis for renal handling and body fluid distribution in heart failure pathophysiology
Doctor H. Kataoka (Saiki, JP)
Abstract Slides
Presentation thumbnail
Risk factors and outcomes of hospital-acquired heart failure in medical patients with no pre-existing cardiac dysfunction
Doctor V. kittipibul (Durham, US)
Abstract Slides
Presentation thumbnail
Biological variation of extracellular matrix biomarkers in patients with stable chronic heart failure
Doctor T. Taeger (Heidelberg, DE)
Abstract
Presentation thumbnail
Clinical and analytical patterns and the different mechanisms of cardiorenal syndrome.
Doctor H. de Barros Viegas (Setubal, PT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Acute heart failure

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources